Articles related to BREAST SURGERY

As we continue to improve the sensitivity of breast imaging, the need for surgical excision of benign proliferative lesions diagnosed on core needle biopsy remains a contentious topic, calling for careful examination of acceptable excision thresholds, patient preferences, and potential disparities in care.

The imminent CMS coding changes, leading to massive pay cuts, threaten to significantly reduce the availability of DIEP flap breast reconstruction, a procedure renowned for its superior patient outcomes. The potential repercussions, such as increased health disparities and a loss of specialized surgical skills, underscore the urgent need for policy reconsideration.

The video features an interview with Dr. Jason Mouabbi, a surgical oncologist, who discusses the management of invasive lobular carcinoma (ILC), a type of breast cancer that is less common than other types. He explains that ILC is more challenging to diagnose than other breast cancers because it does not form a lump, but rather spreads in a linear fashion throughout the breast tissue. Dr. Mouabbi highlights the importance of early detection and screening for ILC. He then discusses the treatment options for ILC, which may include surgery, radiation therapy, and hormone therapy. He emphasizes the need for personalized treatment plans for each patient based on their specific case and individual needs. Dr. Mouabbi also talks about the potential role of neoadjuvant therapy in improving outcomes for patients with ILC. Overall, the video provides valuable insights into the management of ILC and highlights the importance of early detection and personalized treatment plans.

The National Cancer Database analysis highlights the difficulty in identifying a single time point before which primary surgery should be completed in patients with breast cancer. There were two major findings: (1) 12% of patients who had surgery more than 8 weeks after diagnosis had significantly lower overall survival, and (2) patients with lower socioeconomic status had a longer time to surgery.

The majority of the decrease in the risk of local recurrence was seen in the first decade, according to the researchers’ observations of a differential effect over time. With or without irradiation, the risk of recurrence is not significantly different in the second decade. However, others pointed out that the goal of radiotherapy is not to increase overall survival but rather to lower the risk of local recurrence, which is a crucial aspect of breast-conserving therapy.

This six-chapter video series covers patient selection for neoadjuvant systemic treatment, adjuvant systemic treatment, neoadjuvant systemic treatment, post-neoadjuvant adjuvant treatment, survivorship and surveillance, and future directions.